GRP78 targeting with antibodies exhibited a decrease in cell proliferation and tumour growth, apoptosis induction and improved efficacy of radiation therapy in human glioblastoma and non-small cell lung cancer [64]. This evidence concerns the gene HSPA5 and neoplasm.